NCT03507413 - Metformin Therapy in Non-diabetic AAA Patients | Biotech Hunter

Enrollment

170

Participants

Timeline

Start Date

September 26, 2018

Primary Completion Date

May 1, 2024

Study Completion Date

May 1, 2024

Conditions

Abdominal Aortic Aneurysm

Interventions

DRUG

Metformin Glucophage 500mg (IR) tablets M90

oral metformin Glucophage treatment 500 mg daily (2-0-2) for 1 year

DRUG

Placebo Oral Tablet

Placebo Oral Tablet M90 treatment twice daily (2-0-2) for 1 year

Trial Locations (1)

Medical University of Vienna, Department of Surgery, Division of Vascular Surgery, Vienna

All Listed Sponsors

collaborator

Merck Serono GmbH, Germany

INDUSTRY

lead

Medical University of Vienna

OTHER